Lemaitre Vascular (LMAT) FCF Payout Ratio Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 156.68% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 20.33% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -5.34% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 123.82% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -49.82% |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn | -21.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.37% |
| Dec 31, 2025 | -22.56% |
| Sep 30, 2025 | -40.11% |
| Jun 30, 2025 | -48.57% |
| Mar 31, 2025 | -39.16% |
| Dec 31, 2024 | -16.75% |
| Sep 30, 2024 | -1.20% |
| Jun 30, 2024 | 35.45% |
| Mar 31, 2024 | -95.34% |
| Dec 31, 2023 | -66.28% |
| Sep 30, 2023 | -27.57% |
| Jun 30, 2023 | 3.22% |
| Mar 31, 2023 | 3,065.67% |
| Dec 31, 2022 | 80.56% |
| Sep 30, 2022 | 104.06% |
| Jun 30, 2022 | 24.29% |
| Mar 31, 2022 | 45.66% |
| Dec 31, 2021 | 261.30% |
| Sep 30, 2021 | 37.52% |
| Jun 30, 2021 | -29.89% |
| Mar 31, 2021 | -92.33% |
| Dec 31, 2020 | -63.10% |
| Sep 30, 2020 | -68.34% |
| Dec 31, 2019 | 56.11% |
| Sep 30, 2019 | 23.98% |
| Dec 31, 2018 | 25.81% |
| Sep 30, 2018 | 101.75% |
| Dec 31, 2017 | -21.37% |
| Sep 30, 2017 | 36.90% |
| Dec 31, 2016 | 16.29% |
| Sep 30, 2016 | -36.70% |
| Dec 31, 2015 | -15.23% |
| Sep 30, 2015 | -8.70% |
| Dec 31, 2014 | -39.08% |
| Sep 30, 2014 | -0.65% |
| Dec 31, 2013 | -99.31% |
| Sep 30, 2013 | -80.02% |
| Dec 31, 2012 | 18,918.18% |
| Sep 30, 2012 | 27.55% |